Table of Content
- 1. Executive Summary
- 2. Industry Introduction, including Taxonomy and Market Definition
- 3. Trends and Success Factors, Including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
- 4. Global Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, Including Historical Analysis and Future Projections
- 5. Pricing Analysis
- 6. Global Analysis 2019 to 2023 and Forecast 2024 to 2034
- 6.1. Application
- 6.2. Technology
- 7. Global Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application
- 7.1. Residential
- 7.2. Industrial
- 7.3. Commercial
- 8. Global Analysis 2019 to 2023 and Forecast 2024 to 2034, By Technology
- 8.1. Sensors
- 8.2. Dimmers
- 8.3. Day Light Harvesting
- 8.4. Time Scheduling
- 9. Global Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
- 9.1. North America
- 9.2. Latin America
- 9.3. Western Europe
- 9.4. South Asia and Pacific
- 9.5. East Asia
- 9.6. Eastern Europe
- 9.7. Middle East & Africa
- 10. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 11. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 12. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 13. South Asia and Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 14. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 15. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 16. Middle East & Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 17. Sales Forecast 2024 to 2034 by Application and Technology for 30 Countries
- 18. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
- 19. Company Profiles
- 19.1. Pfizer Inc.
- 19.2. Sangamo Therapeutics
- 19.3. BioMarin Pharmaceuticals
- 19.4. F.Hoffman-La-Roche AG
- 19.5. UniQure
- 19.6. Shire Plc
